Guided Therapeutics, Inc. (GTHP)
OTCMKTS: GTHP · Delayed Price · USD
0.144
+0.053 (58.13%)
Jul 3, 2024, 10:44 AM EDT - Market closed
Company Description
Guided Therapeutics, Inc., a medical technology company, develops medical devices.
It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008.
Guided Therapeutics, Inc. was incorporated in 1992 and is headquartered in Peachtree Corners, Georgia.
Guided Therapeutics, Inc.
| Country | United States |
| Founded | 1992 |
| IPO Date | Jul 1, 1997 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Dr. Mark L. Faupel Ph.D. |
Contact Details
Address: 5835 Peachtree Corners East, Suite B Peachtree Corners, Georgia 30092 United States | |
| Phone | (770) 242-8723 |
| Website | guidedinc.com |
Stock Details
| Ticker Symbol | GTHP |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000924515 |
| CUSIP Number | 40171F501 |
| ISIN Number | US40171F5017 |
| Employer ID | 58-2029543 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. Gene S. Cartwright Ph.D. | Chief Executive Officer, President, Acting Chief Financial Officer and Director |
| Dr. Mark L. Faupel Ph.D. | Chief Operating Officer, Secretary and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 14, 2024 | 10-Q | Quarterly Report |
| Mar 28, 2024 | 10-K | Annual Report |
| Feb 20, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 13, 2023 | 10-Q | Quarterly Report |
| Aug 10, 2023 | 10-Q | Quarterly Report |
| May 15, 2023 | 10-Q | Quarterly Report |
| Mar 30, 2023 | 10-K | Annual Report |
| Mar 9, 2023 | 8-K | Current Report |
| Feb 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |